Analysts high on Xilinx amid margin concern
Dylan McGrath, EETimes
7/21/2011 1:55 PM EDT
SAN FRANCISCO—Analysts remained mostly bullish on programmable logic vendor Xilinx Inc. following the company's earnings report Wednesday (July 20) despite some concerns about the company's declining gross margins.
"We came away from the earnings call more positive than the numerical results and guidance reflect, as we believe gross margins are on track to rapidly recover and there is ample runway on improving gross margins and op-ex by optimizing business practices (i.e. tiered volume pricing) in upcoming quarters and years," wrote Ian Ing, an analyst with Gleacher and Co., in a report circulated Thursday.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- Xilinx Versal HBM Series with Integrated High Bandwidth Memory Tackles Big Data Compute Challenges in the Network and Cloud
- Another Industry first: Extreme Networking- 1K TCP & UDP Session on intel/Xilinx FPGAs, high availability application performance - 2U Accelerator box with Linux iWARP/RoCE
- AMD to Acquire Xilinx, Creating the Industry's High Performance Computing Leader
- High Performance Channel Coding Solutions on Xilinx Zynq UltraScale+ RFSoC Devices
- Faraday Reports 2018 Annual Revenues of NT$4.91 Billion, NRE NT$1.3 Billion, up 107% YoY; 2018 Gross Margin was 53.1%, a 11 Year High
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






